查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1668546

2025年全球呼吸侦测市场报告

Respiratory Disease Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年呼吸疾病检测市场规模将强劲成长。到 2029 年，这一数字将成长至 46.6 亿美元，复合年增长率为 5.6%。预测期内的成长将受到空气传播呼吸道病毒的增加、对家庭检测解决方案的关注、精准医疗研究的增加、持续的环境健康问题以及对早期疗育和预防的关注的推动。预测期内的关键趋势包括就地检验、人工智慧 (AI) 整合、远端监控技术、远端医疗服务、客製化生物标记面板和增强呼吸分析技术。

呼吸系统疾病的盛行率正在上升，预计在不久的将来这将显着提振呼吸系统疾病检测市场。呼吸系统疾病包括影响呼吸系统的疾病，包括肺部、支气管、气管、喉、咽和鼻腔。呼吸系统疾病检测的主要目标是早期发现和诊断，然后及时治疗和管理。这种积极的方法不仅对于阻止疾病进展至关重要，而且对于控制传染性呼吸道疾病的传播和降低併发症的风险也至关重要。例如，根据非传染性疾病联盟2022年9月发布的资料，肺癌是全球癌症死亡的首要原因，预计每年新增病例220万例，死亡病例180万例。慢性呼吸道疾病影响全球5.5亿成年人，造成420万人死亡，占所有病例的7%。因此，呼吸系统疾病盛行率的上升是呼吸系统疾病检测市场的主要驱动力。

预计未来几年吸烟率的提高将推动呼吸系统疾病检测市场的成长。吸烟包括燃烧烟草植物（Nicotiana tabacum）的干燥叶子并吸入产生的烟雾。呼吸系统疾病检测对于吸烟者的健康管理至关重要，监测肺功能随时间的变化可以让医疗保健专业人员评估戒烟倡议的成功程度并相应地修改治疗计画。例如，2024年9月，美国政府机构疾病管制与预防中心报告称，烟草使用仍然是美国可预防疾病和死亡的主要原因。报告显示，到2022年，约有4,920万成年人（占19.8%）使用烟草製品，占人口的近五分之一。因此，吸烟率的上升正在推动呼吸系统疾病检测市场的扩张。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球呼吸医学检测PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球呼吸侦测市场：成长率分析
  • 全球呼吸侦测市场表现：规模与成长，2019-2024
  • 全球呼吸侦测市场预测：规模与成长，2024-2029 年，2034 年
  • 全球呼吸测试总目标市场（TAM）

第六章市场区隔

  • 全球呼吸系统疾病检测市场：按检测类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 影像检查
  • 机械检查
  • 体外诊断测试
  • 全球呼吸系统疾病检测市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 肺活量
  • 影像学
  • 肺量计
  • 尖峰流量
  • 血气
  • 其他产品
  • 全球呼吸系统疾病检测市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 慢性阻塞性肺病
  • 肺癌
  • 气喘
  • 患有肺结核的女人
  • 其他应用
  • 全球呼吸系统疾病检测市场（依最终使用者、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 医生诊所
  • 临床实验室
  • 其他最终用户
  • 全球呼吸系统疾病检测市场，按类型细分：影像检查、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • X射线
  • 电脑断层扫描 (CT)
  • 磁振造影（MRI）
  • 正子断层扫描（PET）
  • 全球呼吸系统疾病检测市场，按类型细分：机械测试、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 肺量计
  • 峰值流量测量
  • 肺容积测量
  • 扩散容量测试
  • 全球呼吸系统疾病检测市场，按类型细分：体外诊断测试、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • PCR检测
  • 抗原检测
  • 抗体检测
  • 文化

第七章 区域和国家分析

  • 全球呼吸系统疾病检测市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球呼吸系统疾病检测市场：依国家/地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 呼吸侦测市场：竞争格局
  • 呼吸侦测市场：公司简介
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • ResMed Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Thermo Fisher Scientific Inc.
  • Becton Dickinson and Company
  • F. Hoffmann-La Roche Ltd.
  • Nihon Kohden Corporation
  • GE HealthCare Technologies Inc.
  • Fisher & Paykel Healthcare Corporation Limited
  • Qiagen NV
  • Medical Graphics Corporation
  • COSMED srl
  • ndd Medizintechnik AG
  • Vitalograph Ltd.
  • MGC Diagnostics Corporation
  • Vyaire Medical Inc.
  • Masimo Corporation
  • Hamilton Medical AG

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年呼吸系统疾病检测市场：提供新机会的国家
  • 2029年呼吸系统疾病检测市场：细分市场将带来新机会
  • 2029年呼吸侦测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r24454

Respiratory disease testing encompasses the diagnostic process of evaluating various respiratory conditions through physical examinations. This procedure aids in the identification and measurement of lung conditions, assessing the speed at which a patient can exhale air. The results of these tests can assist clinicians in diagnosing respiratory diseases, even before patients exhibit symptoms.

The primary categories of tests involved in respiratory disease testing include imaging tests, mechanical tests, and in-vitro diagnostic tests. Imaging tests constitute a subset of diagnostic procedures that generate detailed images of various bodily regions. These tests utilize products such as lung volume imaging, spirometry, peak flow, blood gas, among others. They find applications in various respiratory conditions such as chronic obstructive pulmonary disease, lung cancer, asthma, and tuberculosis. These tests are typically conducted in hospitals, physician clinics, clinical laboratories, and other healthcare settings.

The respiratory disease testing market research report is one of a series of new reports from The Business Research Company that provides respiratory disease testing market statistics, including respiratory disease testing industry global market size, regional shares, competitors with a respiratory disease testing market share, detailed respiratory disease testing market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory disease testing industry. This respiratory disease testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The respiratory disease testing market size has grown steadily in recent years. It will grow from$3.6 billion in 2024 to $3.75 billion in 2025 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to environmental factors and pollution, tobacco smoking epidemic, occupational respiratory hazards, awareness and health education programs, government initiatives for disease control

The respiratory disease testing market size is expected to see strong growth in the next few years. It will grow to $4.66 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to rise in airborne respiratory viruses, focus on home-based testing solutions, increased research in precision medicine, continued environmental health concerns, focus on early intervention and prevention. Major trends in the forecast period include point-of-care testing, integration of artificial intelligence (ai), remote monitoring technologies, telehealth services, customized biomarker panels, enhanced breath analysis techniques.

The upward trajectory in the prevalence of respiratory diseases is poised to significantly boost the respiratory disease testing market in the foreseeable future. Respiratory diseases encompass medical conditions affecting the respiratory system, including the lungs, bronchi, trachea, larynx, pharynx, and nasal passages. The primary purpose of respiratory disease testing is early detection and diagnosis, facilitating prompt treatment and management. This proactive approach not only helps impede disease progression but is also crucial for controlling the transmission of infectious respiratory diseases and reducing the risk of complications. For instance, in September 2022, data from the NCD Alliance revealed that lung cancer ranked as the leading cause of global cancer deaths, with an anticipated 2.2 million new cases and 1.8 million fatalities annually. Chronic respiratory disorders affected 550 million adults globally, resulting in 4.2 million deaths, accounting for 7% of the total. Therefore, the rising prevalence of respiratory diseases is a key driver for the respiratory disease testing market.

The increasing prevalence of tobacco smoking is anticipated to boost the growth of the respiratory disease testing market in the future. Tobacco smoking involves the combustion of dried leaves from the tobacco plant (Nicotiana tabacum) and inhaling the smoke produced. Respiratory disease testing is essential for managing the health of tobacco smokers, as it monitors changes in lung function over time, enabling healthcare professionals to evaluate the success of smoking cessation initiatives and modify treatment plans accordingly. For instance, in September 2024, the Centers for Disease Control and Prevention, a US government agency, reported that tobacco use remains the leading cause of preventable illness and death in the United States. In 2022, around 49.2 million adults, or 19.8%-nearly 1 in 5-indicated they used tobacco products. Consequently, the rising incidence of tobacco smoking is driving the expansion of the respiratory disease testing market.

Technological advancements are emerging as a prominent trend in the respiratory disease testing market, with major companies focusing on innovative solutions to enhance treatment protocols and elevate patient outcomes. A notable example is Respira Labs, a U.S.-based healthcare technology company, which introduced the AI-powered wearable device, Sylvee, in March 2022. Sylvee, worn as a chest strap, employs artificial intelligence and machine learning algorithms to analyze data from multiple sensors measuring breathing rate, volume, and patterns. This device aids in the early diagnosis and management of conditions such as chronic obstructive pulmonary disease (COPD), asthma, and COVID-19, utilizing advanced AI algorithms to analyze breath sounds and provide real-time feedback on lung function.

Major players in the respiratory disease testing market are actively engaged in developing advanced products, such as pulmonary function testing, to establish a competitive advantage. A case in point is Vitalograph Ltd., a UK-based provider of respiratory diagnostics, which launched the VitaloPFT series in March 2023. This series offers detailed pulmonary function testing options, providing healthcare providers with a cost-effective solution for advanced respiratory diagnostics. Its user-friendly design simplifies the testing process, enhancing accessibility for healthcare professionals.

In January 2023, CAIRE Inc., a prominent U.S.-based medical supply and manufacturing company, completed the acquisition of MGC Diagnostics Holdings for an undisclosed amount. This strategic move is driven by CAIRE Inc.'s objective to expand the scope of its product line, diversify its income streams, and fortify its position as a leading player in the medical technology sector, specifically focusing on respiratory and cardiorespiratory diagnostics. MGC Diagnostics Holdings Inc., the acquired entity, is a U.S.-based medical technology company specializing in offering comprehensive cardiorespiratory diagnostic solutions and respiratory disease testing products.

Major companies operating in the respiratory disease testing market include Medtronic plc, Abbott Laboratories, Seimens Healthineers AG, Koninklijke Philips N.V., ResMed Inc., Thermo Fisher Scientific Inc., Beckton Dickinson And Company, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, GE HealthCare Technologies Inc., Fisher And Paykel Healthcare Corporation Limited, Qiagen N.V., Medical Graphics Corporation, COSMED srl, ndd Medizintechnik AG, Vitalograph Ltd., MGC Diagnostics Corporation, Vyaire Medical Inc., Masimo Corporation, Hamilton Medical AG, Dragerwerk AG & Co. KGaA, Schiller AG, Nonin Medical Inc., Natus Medical Incorporated

North America was the largest region in the respiratory disease testing market in 2024. Asia-Pacific is expected to be the fastest growing region in the global respiratory disease testing market during the forecast period. The regions covered in the respiratory disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the respiratory disease testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The respiratory disease testing market includes revenues earned by entities by providing services such as exhaled nitric oxide tests lung function tests. oxygen therapy, bronchoscopy, ultrasonography, nuclear lung scanning, and pulmonary artery angiography. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Respiratory Disease Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on respiratory disease testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for respiratory disease testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The respiratory disease testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Imaging Tests; Mechanical Tests; In-Vitro Diagnostic Tests
  • 2) By Products: Lung Volume; Imaging; Spirometry; Peak Flow; Blood Gas; Other Products
  • 3) By Application: Chronic Obstructive Pulmonary Disease; Lung Cancer; Asthma; Tuberculosis Female; Other Application
  • 4) By End-User: Hospitals; Physician clinics; Clinical laboratories; Other End-User
  • Subsegments:
  • 1) By Imaging Tests: X-rays; Computed Tomography (CT) Scans; Magnetic Resonance Imaging (MRI); Positron Emission Tomography (PET) Scans
  • 2) By Mechanical Tests: Spirometry; Peak Flow Measurement; Lung Volume Measurement; Diffusion Capacity Tests
  • 3) By In-Vitro Diagnostic Tests: PCR Tests; Antigen Tests; Antibody Tests; Culture Tests
  • Companies Mentioned: Medtronic plc; Abbott Laboratories; Seimens Healthineers AG; Koninklijke Philips N.V.; ResMed Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Respiratory Disease Testing Market Characteristics

3. Respiratory Disease Testing Market Trends And Strategies

4. Respiratory Disease Testing Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Respiratory Disease Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Respiratory Disease Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Respiratory Disease Testing Market Growth Rate Analysis
  • 5.4. Global Respiratory Disease Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Respiratory Disease Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Respiratory Disease Testing Total Addressable Market (TAM)

6. Respiratory Disease Testing Market Segmentation

  • 6.1. Global Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Imaging Tests
  • Mechanical Tests
  • In-Vitro Diagnostic Tests
  • 6.2. Global Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lung Volume
  • Imaging
  • Spirometry
  • Peak Flow
  • Blood Gas
  • Other Products
  • 6.3. Global Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chronic Obstructive Pulmonary Disease
  • Lung Cancer
  • Asthma
  • Tuberculosis Female
  • Other Application
  • 6.4. Global Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Physician clinics
  • Clinical laboratories
  • Other End-User
  • 6.5. Global Respiratory Disease Testing Market, Sub-Segmentation Of Imaging Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • X-rays
  • Computed Tomography (CT) Scans
  • Magnetic Resonance Imaging (MRI)
  • Positron Emission Tomography (PET) Scans
  • 6.6. Global Respiratory Disease Testing Market, Sub-Segmentation Of Mechanical Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spirometry
  • Peak Flow Measurement
  • Lung Volume Measurement
  • Diffusion Capacity Tests
  • 6.7. Global Respiratory Disease Testing Market, Sub-Segmentation Of In-Vitro Diagnostic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR Tests
  • Antigen Tests
  • Antibody Tests
  • Culture Tests

7. Respiratory Disease Testing Market Regional And Country Analysis

  • 7.1. Global Respiratory Disease Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Respiratory Disease Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Respiratory Disease Testing Market

  • 8.1. Asia-Pacific Respiratory Disease Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Respiratory Disease Testing Market

  • 9.1. China Respiratory Disease Testing Market Overview
  • 9.2. China Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Respiratory Disease Testing Market

  • 10.1. India Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Respiratory Disease Testing Market

  • 11.1. Japan Respiratory Disease Testing Market Overview
  • 11.2. Japan Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Respiratory Disease Testing Market

  • 12.1. Australia Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Respiratory Disease Testing Market

  • 13.1. Indonesia Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Respiratory Disease Testing Market

  • 14.1. South Korea Respiratory Disease Testing Market Overview
  • 14.2. South Korea Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Respiratory Disease Testing Market

  • 15.1. Western Europe Respiratory Disease Testing Market Overview
  • 15.2. Western Europe Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Respiratory Disease Testing Market

  • 16.1. UK Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Respiratory Disease Testing Market

  • 17.1. Germany Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Respiratory Disease Testing Market

  • 18.1. France Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Respiratory Disease Testing Market

  • 19.1. Italy Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Respiratory Disease Testing Market

  • 20.1. Spain Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Respiratory Disease Testing Market

  • 21.1. Eastern Europe Respiratory Disease Testing Market Overview
  • 21.2. Eastern Europe Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Respiratory Disease Testing Market

  • 22.1. Russia Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Respiratory Disease Testing Market

  • 23.1. North America Respiratory Disease Testing Market Overview
  • 23.2. North America Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Respiratory Disease Testing Market

  • 24.1. USA Respiratory Disease Testing Market Overview
  • 24.2. USA Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Respiratory Disease Testing Market

  • 25.1. Canada Respiratory Disease Testing Market Overview
  • 25.2. Canada Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Respiratory Disease Testing Market

  • 26.1. South America Respiratory Disease Testing Market Overview
  • 26.2. South America Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Respiratory Disease Testing Market

  • 27.1. Brazil Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Respiratory Disease Testing Market

  • 28.1. Middle East Respiratory Disease Testing Market Overview
  • 28.2. Middle East Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Respiratory Disease Testing Market

  • 29.1. Africa Respiratory Disease Testing Market Overview
  • 29.2. Africa Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Respiratory Disease Testing Market Competitive Landscape And Company Profiles

  • 30.1. Respiratory Disease Testing Market Competitive Landscape
  • 30.2. Respiratory Disease Testing Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. ResMed Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Respiratory Disease Testing Market Other Major And Innovative Companies

  • 31.1. Thermo Fisher Scientific Inc.
  • 31.2. Becton Dickinson and Company
  • 31.3. F. Hoffmann-La Roche Ltd.
  • 31.4. Nihon Kohden Corporation
  • 31.5. GE HealthCare Technologies Inc.
  • 31.6. Fisher & Paykel Healthcare Corporation Limited
  • 31.7. Qiagen N.V.
  • 31.8. Medical Graphics Corporation
  • 31.9. COSMED srl
  • 31.10. ndd Medizintechnik AG
  • 31.11. Vitalograph Ltd.
  • 31.12. MGC Diagnostics Corporation
  • 31.13. Vyaire Medical Inc.
  • 31.14. Masimo Corporation
  • 31.15. Hamilton Medical AG

32. Global Respiratory Disease Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Respiratory Disease Testing Market

34. Recent Developments In The Respiratory Disease Testing Market

35. Respiratory Disease Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Respiratory Disease Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Respiratory Disease Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Respiratory Disease Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer